ÂÜÀòÂÒÂ×

Matt Birrell has extensive experience in business development and corporate finance. Matt most recently served as the Executive Business Development Director at Rigel Pharmaceuticals Inc. starting in December 2021. Prior to that, they worked at Portola Pharmaceuticals for 17 years, where they held the position of Senior Director, Business Development. Before joining Portola Pharmaceuticals, Matt worked in corporate development at COR Therapeutics from 1999 to 2002. Matt began their career in corporate finance at Hambrecht & Quist, where they worked from 1995 to 1998.

Matt Birrell attended Princeton University from 1990 to 1995. No information is available regarding their degree or field of study during this period.